image
Healthcare - Biotechnology - NASDAQ - US
$ 1.16
6.94 %
$ 3.81 M
Market Cap
-0.33
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
19.05%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Artelo Biosciences, Inc.
image
ARTL has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ARTL

image
$100.0m$100.0m$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ARTL

image
$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ARTL

image
$1.0m$1.0m$0.0$0.0($1.0m)($1.0m)($2.0m)($2.0m)($3.0m)($3.0m)($4.0m)($4.0m)($5.0m)($5.0m)($6.0m)($6.0m)($7.0m)($7.0m)($8.0m)($8.0m)($9.0m)($9.0m)($10.0m)($10.0m)2022202220232023202420242025202520262026202720272028202820292029